Two radically resected colorectal carcinoma cases with unresectable liver metastasis after adjuvant chemotherapy with bevacizumab

Masahiko Sugiyama, Yoshihiro Kakeji, Nobuhide Kubo, Tomonori Nakanoko, Yoshihiko Fujinaka, Kouji Ando, Takanobu Masuda, Kenji Yagi, Keishi Yoshinaga, Hiroshi Saeki, Kazuya Endo, Yasunori Emi, Masaru Morita, Yoshihiko Maehara

研究成果: Contribution to journalArticle査読

抄録

Nowadays, the advancements of systemic chemotherapy for colorectal carcinoma improve a clinical response rate, and expand the possibility of resection which couldn't operable at the initial visit. In addition, the prognoses of the patients, who had a radical operation for metastasis, are clearly longer than the non-operable patients. Bevacizumab, anti-human VEGF monoclonal antibody, is significantly effective when used in combination with one of the systemic multi-agent chemotherapy such as FOLFOX regimen or FOLFIRI regimen. We report here two cases with colon carcinoma, which had initially unresectable liver metastases, were respond to the treatment of systemic multi-agent chemotherapy with bevacizumab. Then, both cases were able to undergo radical resections of primary tumor and liver metastases safely.

本文言語英語
ページ(範囲)2169-2171
ページ数3
ジャーナルJapanese Journal of Cancer and Chemotherapy
36
12
出版ステータス出版済み - 11 2009

All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 癌研究

フィンガープリント

「Two radically resected colorectal carcinoma cases with unresectable liver metastasis after adjuvant chemotherapy with bevacizumab」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル